JTJinyun Tan

Jinyun Tan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jinyun Tan has a total of 124 co-authors. Here are the top co-authors by number of shared publications:

  • Bo Yu

    Department of Vascular Surgery Division, General Surgery Department, Huashan Hospital Affiliated to Fudan University

    8 shared publications
  • Weihao Shi

    Department of Vascular Surgery Huashan Hospital Affiliated to Fudan University Shanghai China

    7 shared publications
  • Lei Zhu

    Department of Vascular Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, China

    6 shared publications
  • Qing He

    Vascular Surgery Division, General Surgery Department, Huashan Hospital Affiliated to Fudan University, Shanghai, China (J. Tan, Q.H., W.G., K.L., W.S., B.Y.).

    5 shared publications
  • Weijian Fan

    Department of Vascular Surgery Huashan Hospital of Fudan University Shanghai P. R. China

    5 shared publications
  • Lei Zhang

    National Engineering Research Center of Light Alloy Net Forming & State Key Laboratory of Metal Matrix Composite, School of Materials Science & Engineering, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai, 200240, China

    4 shared publications

Latest Publications

  • Open Access

    Metal-based hydrogen-generating therapeutic systems: From reactive chemistry to route-specific exposure and translational design

    by Shengwei Zhang, Weijian Fan, Zhiheng Xu, Zhiqin Zhen, Songnan Qu, Jinyun Tan

  • Integrated thermal sensing of vascular morphology for haemodynamic monitoring

    by Yuqi Tian, Yujun Deng, Jinyun Tan, Linfa Peng, Zhongqin Lin

  • Top Cited Papers
    Open Access

    Wireless, non-invasive, high-resolution thrill sensor for continuous vascular access monitoring of hemodialysis patients

    by Yicong Wang, Jie Wang, Yuqi Tian, Zhiheng Xu, Mengyao Liu, Lin Zhou, Renhua Lv, Yujun Deng, Jinyun Tan, Linfa Peng, et al.

    Hemodialysis is the primary life-sustaining therapy for patients with end-stage renal disease (ESRD). Diagnosing and monitoring the health condition of vascular access (VA) for hemodialysis involves the use of ultrasonic imaging and angiography. These infrequent tests cannot, however, identify signs of mild stenosis and sudden onset to facilitate early intervention. Hence, approximately 70% of hemodialysis patients experience VA failure each year, rendering dialysis difficult and posing life-threatening risks. Here, we report wireless, non-invasive thrill sensors incorporating high-resolution accelerometers designed to be conformally placed on VA skin for the continuous monitoring of VA thrill signals, which we tested in multi-platform validation including an in vitro benchtop system, canine models and patients (n = 9). Local measurements of VA thrill intensity via continuous wear demonstrated that a decrease in thrill intensity along the entire VA region is indicative of diminished VA function, while an abnormally heightened thrill intensity at a certain location along the VA indicates localized structural lesions. These thrill sensors may aid the early treatment of VA stenosis upon the transition from subjective thrill palpation to quantitative hemodynamic phenotyping.


  • Constructing Mg‐Based Hydrogen Container for Mitochondrial Dysfunction and Neuronal Ferroptosis in TCAR‐Induced Cerebral Ischemia/Reperfusion Injury

    by Weijian Fan, Qingqing Guan, Zhiheng Xu, Lanmei Lin, Juan Du, Bo Yu, Wenjiang Ding, Haiyan Yang, Jia Pei, Jinyun Tan

    Mitochondrial dysfunction and reactive oxygen species (ROS) overexpression are crucial factors inducing neuronal ferroptosis in cerebral ischemia/reperfusion injury (CIRI). Some therapeutics like RNAs and anti‐oxidation drugs have been developed to regulate the functions of mitochondria, but are hardly delivered into brain effectively due to the blood‐brain barrier (BBB). H 2 has recently been verified able to overcome the BBB efficiently and has a unique wide‐spectrum anti‐oxidation/anti‐inflammation effect, but sustainable, high‐amount, and safe delivery of H 2 into brain is still challenging currently. Herein, we develop an innovative H 2 administration method of intraperitoneal injection of magnesium hydride microparticles (MgH 2 ) with a high payload of hydrogen and a sustained hydrolytic H 2 production behavior, achieving persistent and high‐dose supply of H 2 into the blood system as well as in the brain. In addition, we establish a novel CIRI rabbit model induced by transcarotid artery revascularization (TCAR), which leads to oxidative stress and subsequent ferroptosis in the brain's hippocampus. In this CIRI model, MgH 2 treatment eliminates intracellular ROS, inhibits neuronal ferroptosis, and recovers mitochondrial dysfunction by stabilizing mitochondrial membrane potential, regulating mitobiogenesis, promoting neuronal energy metabolism, and activating the anti‐oxidative pathway. All these findings demonstrate that MgH 2 treatment provides a potential strategy for CIRI.


  • Open Access

    Bioadhesive and conformable bioelectronic interfaces for vasomotoricity monitoring and regulation

    by Xiner Wang, Weijian Fan, Yuxin Liu, Li Chen, Erda Zhou, Xiaoling Wei, Liuyang Sun, Bo Yu, Tiger H. Tao, Zhitao Zhou, et al.

    The autonomic nervous system (ANS) dynamically regulates vasomotor function to maintain vascular homeostasis, yet current clinical tools lack the capacity to capture its electrophysiological basis, particularly following stent implantation. Herin, we report a bioadhesive and conformable bioelectronic (BACE) interface engineered for effective monitoring and modulation of vasomotoricity. Incorporating silk fibroin-based adhesives, the interface adheres robustly to cylindrical surfaces in aqueous conditions for up to two months. It exhibits low interfacial impedance (6.77 ± 2.13 kΩ at 1 kHz) and background noises (2.63 ± 0.52 μV) in vivo, enabling precise recording of varying vasomotor states. In a stent model, the interface identifies alterations in bioelectrical activity associated with vasomotor dysfunction, validated against ultrasound-derived arterial stiffness as clinical gold standards. Furthermore, we demonstrate a bidirectional system for the detection and modulation of dysfunction to restore vasomotor activity and elasticity. These findings provide insights into vasomotor electrophysiology mechanisms and underscore the therapeutic potential of bioelectronic modulation in vascular disease.


  • Open Access

    IL-17A-driven Macrophage Disorder Promotes Plaque Instability in Psoriatic Atherosclerosis

    by Canbing Dong, Jie Wang, Jui-Ming Lin, Xiaonian Lu, Junhao Zhu, Lanmei Lin, Lin Zhou, Fang Liu, Dan Wu, Xinyi Zhu, et al.

    Psoriasis is a common chronic inflammatory skin disease that predisposes individuals to cardiovascular diseases such as atherosclerosis. However, the underlying mechanisms linking these conditions have not yet been fully elucidated. Recent studies have indicated that the inflammatory cytokine IL-17A plays a significant role in both diseases. The aim of this study was to investigate how psoriasis affects the stability of atherosclerotic plaques via the IL-17A/IL-17RA pathway. We performed single-cell sequencing on patients with both psoriasis and atherosclerosis to analyze changes in the immune microenvironment within their carotid plaques and psoriatic lesions. We found that IL-17A significantly upregulated the expression of pro-inflammatory factors (e.g., CXCL8) in macrophages of psoriatic atherosclerosis patients, leading to weakening of the fibrous cap structure of plaques. Additionally, IL-17A further exacerbated plaque instability by interfering with macrophage lipid metabolism, particularly sphingolipid metabolism. Finally, using in vitro experiments and animal models, we demonstrated that IL-17A enhances pro-inflammatory and metabolic abnormalities in macrophages by downregulating PPARγ. Therapeutic strategies targeting IL-17A may contribute to the simultaneous mitigation of psoriasis and atherosclerosis-associated cardiovascular risk, providing new directions for clinical intervention.

  • Open Access

    Dual regulation of Atf3 and Lonp1 as therapeutic targets in cerebral ischaemia-reperfusion injury

    by Weijian Fan, Min Zhou, Lin Zhou, Jindong Tong, Jinyun Tan, Weihao Shi, Bo Yu

    Background: Cerebral ischemia-reperfusion injury (CIRI) leads to cognitive dysfunction, neuronal death, and inflammation. Understanding the molecular mechanisms underlying CIRI is crucial for developing effective therapeutic strategies. Objective: This study aims to investigate the roles of activating transcription factor 3 (Atf3) and lon protease homolog 1 (Lonp1) in CIRI, particularly focusing on how Atf3 regulates Lonp1 expression and its effects on mitochondrial function. Methods: Single-cell transcriptomics and proteomic analyses were employed to explore Atf3's influence on Lonp1 and its subsequent impact on neuronal survival and apoptosis. Results: The findings indicate that Atf3 plays a crucial role in modulating Lonp1 expression, which in turn affects mitochondrial function, neuronal survival, and apoptotic pathways. Conclusion: This study provides new insights into the regulatory mechanisms of Atf3 and Lonp1 in CIRI, identifying potential therapeutic targets for managing ischemic brain injury and neurodegenerative diseases.


  • Open Access

    Self-adaptive epidermal blood flow sensor for high-flux vascular access monitoring of hemodialysis patients

    by Yuqi Tian, Kai Yang, Yicong Wang, Jie Wang, Andrea S. Carlini, Zhinan Zhang, Yujun Deng, Jinyun Tan, Linfa Peng, Bo Yu, et al.


  • Open Access

    Antiferroptosis therapy alleviated the development of atherosclerosis

    by Zhou Yang, Yue He, Dejun Wu, Weihao Shi, Ping Liu, Jinyun Tan, Rui Wang, Bo Yu

    Ferroptosis has been confirmed to be associated with various diseases, but the relationship between ferroptosis and atherosclerosis (AS) remains unclear. Our research detailly clarified the roles of ferroptosis in three continuous and main pathological stages of AS respectively (injury of endothelial cells [ECs], adhesion of monocytes, and formation of foam cells). We confirmed that oxidized low‐density lipoprotein (ox‐LDL), the key factor in the pathogenesis of AS, strongly induced ferroptosis in ECs. Inhibition of ferroptosis repressed the adhesion of monocytes to ECs by inhibiting inflammation of ECs. Ferroptosis also participated in the formation of foam cells and lipids by regulating the cholesterol efflux of macrophages. Further research confirmed that ox‐LDL repressedthe activity of glutathione peroxidase 4 (GPX4), the classic lipid peroxide scavenger. Treatment of a high‐fat diet significantly induced ferroptosis in murine aortas and aortic sinuses, which was accompanied by AS lesions and hyperlipidemia. Treatment with ferroptosis inhibitors significantly reduced ferroptosis, hyperlipidemia, and AS lesion development. In conclusion, our research determined that ox‐LDL induced ferroptosis by repressing the activity of GPX4. Antiferroptosis treatment showed promising treatment effects in vivo. Ferroptosis‐associated indexes also showed promising diagnostic potential in AS patients.


  • Open Access

    Single-Cell Transcriptomics Reveals Crucial Cell Subsets and Functional Heterogeneity Associated With Carotid Atherosclerosis and Cerebrovascular Events

    by Jinyun Tan, Yongjun Liang, Zhou Yang, Qing He, Jindong Tong, Ying Deng, Wencheng Guo, Kun Liang, Jingdong Tang, Weihao Shi, et al.

    BACKGROUND: Carotid atherosclerosis is a chronic inflammatory disorder and is responsible for the vast majority of ischemic strokes. Inappropriate innate and adaptive immune responses synergize with malfunctional vascular wall cells to cause atherosclerotic lesions. Yet, functional characteristics of specific immune and endothelial cell subsets associated with atherosclerosis and cerebrovascular events are poorly understood. METHODS: Here, using single-cell RNA sequencing, the unprecedentedly largest data set from 20 patients’ carotid artery plaques and paired peripheral blood mononuclear cells was generated, with which an ultra-high-precision cellular landscape of the atherosclerotic microenvironment involving 372 070 cells was depicted. RESULTS: Compared with peripheral blood mononuclear cells, 3 plaque-specific T-cell subsets exhibiting proatherogenic features of both activation and exhaustion were identified. Strikingly, usually antiatherogenic, CD4 + FOXP3 + regulatory T cells from plaques of patients with symptomatic disease acquired proinflammatory properties by probably converting to T helper 17 and T helper 9 cells, while CD4 + NR4A1 + /C0 and CD8 + SLC4A10 + T cells related to cerebrovascular events possessed atherogenic attributes including proinflammation, polarization, and exhaustion. In addition, monocyte-macrophage dynamics dominated innate immune response. Two plaque-specific monocyte subsets performed diametrically opposed functions, EREG + monocytes promoted cerebrovascular events while C3 + monocytes are anti-inflammatory. Similarly, IGF1 + and HS3ST2 + macrophages with classical proinflammatory M1 macrophage features were annotated and contributed to cerebrovascular events. Moreover, SULF1 + (sulfatase-1) endothelial cells were also found to participate in cerebrovascular events through affecting plaque vulnerability. CONCLUSIONS: This compendium of single-cell transcriptome data provides valuable insights into the cellular heterogeneity of the atherosclerotic microenvironment and the development of more precise cardiovascular immunotherapies.